Modakafusp alfa (formerly TAK-573) is a cytokine that delivers interferon-α2B directly to CD38-positive myeloma cells via anti-CD38 T cells (the interferon binds to a different epitope than that to which anti-CD38 monoclonal antibodies bind). This evidence concerns the gene CD38 and plasma cell myeloma.